These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1982095)

  • 1. Potential therapeutic exploitation of the pulmonary polyamine uptake system.
    Cohen GM; Smith LL
    Biochem Soc Trans; 1990 Oct; 18(5):743-5. PubMed ID: 1982095
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation and function of polyamines in African trypanosomes.
    Willert E; Phillips MA
    Trends Parasitol; 2012 Feb; 28(2):66-72. PubMed ID: 22192816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamine metabolism: a potential therapeutic target in trypanosomes.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemistry of African trypanosomes and its significance for chemotherapy.
    Braide VB
    J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of the trypanocidal activity of methyltriazenes in an animal model by the addition of an amidino group.
    Buddhu S; Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
    Acta Trop; 1991 Apr; 49(1):69-72. PubMed ID: 1678578
    [No Abstract]   [Full Text] [Related]  

  • 6. Trypanosome glucose transporters.
    Barrett MP; Tetaud E; Seyfang A; Bringaud F; Baltz T
    Mol Biochem Parasitol; 1998 Mar; 91(1):195-205. PubMed ID: 9574935
    [No Abstract]   [Full Text] [Related]  

  • 7. Mathematical modelling of polyamine metabolism in bloodstream-form Trypanosoma brucei: an application to drug target identification.
    Gu X; Reid D; Higham DJ; Gilbert D
    PLoS One; 2013; 8(1):e53734. PubMed ID: 23372667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.
    Byers TL; Bush TL; McCann PP; Bitonti AJ
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):527-33. PubMed ID: 1672500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New leads for trypanosomiasis chemotherapy.
    Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
    Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
    Tchalim TK
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
    [No Abstract]   [Full Text] [Related]  

  • 13. A drug resistance determinant in Trypanosoma brucei.
    Carter NS; Barrett MP; de Koning HP
    Trends Microbiol; 1999 Dec; 7(12):469-71. PubMed ID: 10603477
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and mode of action of drugs used against sleeping sickness.
    Denise H; Barrett MP
    Biochem Pharmacol; 2001 Jan; 61(1):1-5. PubMed ID: 11137702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need new drugs against human African trypanosomiasis?
    Stich A; Ponte-Sucre A; Holzgrabe U
    Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine uptake and the modulation of drug sensitivity in
    Macedo JP; Currier RB; Wirdnam C; Horn D; Alsford S; Rentsch D
    FASEB J; 2017 Oct; 31(10):4649-4660. PubMed ID: 28679527
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious disease: Genomics decodes drug action.
    Fairlamb AH
    Nature; 2012 Feb; 482(7384):167-9. PubMed ID: 22318598
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.